Document is current
Any future updates will be listed below
-
Authors
Lakshmi, Kavitha
Jutrzenka-Trzebiatowski, Alexandra von
Loureiro, Liliana
Soto, Karla Elizabeth González
Peter, Katja
Morales, José Manuel Marín
Nirmala, Samikshya Santosh
Berndt, Nicole
Arndt, Claudia
Hu, Yueyuan
Li, Jing-Wun
Peitzsch, Claudia
Taubenberger, Anna
Wehner, Rebekka
Schmitz, Marc
Hölig, Kristina
Abken, Hinrich
Bonifacio, Ezio
Bornhäuser, Martin
Bachmann, Michael
Feldmann, Anja
Fuchs, Anke https://orcid.org/0000-0003-3028-0827
-
Funding
Funding for this research was provided by:
Technische Universität Dresden
- License Information
-
More Information
Article History
Received: 18 August 2025
Accepted: 31 October 2025
First Online: 17 December 2025
Declarations
:
: Teffs for suppression assays were isolated from Buffy Coats obtained from the Deutsches Rotes Kreuz (DRK; Blutspendedienst Ost GmbH Dresden), as a side product of erythrocyte isolation for clinical use after obtaining informed consent. The apheresis procedure to isolate Tregs for genetic modification was performed at the Department of Transfusion Medicine, Carl Gustav Carus University Hospital at Technische Universität Dresden, after obtaining informed consent from the donors (file number EK − 80,022,019). The colon biopsies for immunofluorescent staining were obtained from a single aGvHD patient after informed consent (file No. BO EK11012020).
: Not applicable.
: MBa has filed patents related to the RevCAR system and the anti-La monoclonal antibodies.
